Oncolytics Biotech Inc. Announces Approval to Proceed with Clinical Trial to Evaluate REOLYSIN(R) for the Treatment of Prostate Cancer
...As a secondary endpoint, the Company is measuring tumor response at both the treated lesion as well as remote metastatic sites....... cancer cells derived from many types of cancer including breast, prostate, pancreatic and brain tumours....
Oct 11 9:05 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/011011/to276_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines